Literature DB >> 23876777

Regulatory roles of metabolites in cell signaling networks.

Feng Li1, Wei Xu, Shimin Zhao.   

Abstract

Mounting evidence suggests that cellular metabolites, in addition to being sources of fuel and macromolecular substrates, are actively involved in signaling and epigenetic regulation. Many metabolites, such as cyclic AMP, which regulates phosphorylation/dephosphorylation, have been identified to modulate DNA and histone methylation and protein stability. Metabolite-driven cellular regulation occurs through two distinct mechanisms: proteins allosterically bind or serve as substrates for protein signaling pathways, and metabolites covalently modify proteins to regulate their functions. Such novel protein metabolites include fumarate, succinyl-CoA, propionyl-CoA, butyryl-CoA and crontonyl-CoA. Other metabolites, including α-ketoglutarate, succinate and fumarate, regulate epigenetic processes and cell signaling via protein binding. Here, we summarize recent progress in metabolite-derived post-translational protein modification and metabolite-binding associated signaling regulation. Uncovering metabolites upstream of cell signaling and epigenetic networks permits the linkage of metabolic disorders and human diseases, and suggests that metabolite modulation may be a strategy for innovative therapeutics and disease prevention techniques.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Binding; Epigenetics; Metabolite; Modification; Signaling

Mesh:

Substances:

Year:  2013        PMID: 23876777     DOI: 10.1016/j.jgg.2013.05.002

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  8 in total

1.  Procyclic trypanosomes recycle glucose catabolites and TCA cycle intermediates to stimulate growth in the presence of physiological amounts of proline.

Authors:  Oriana Villafraz; Marc Biran; Erika Pineda; Nicolas Plazolles; Edern Cahoreau; Rodolpho Ornitz Oliveira Souza; Magali Thonnus; Stefan Allmann; Emmanuel Tetaud; Loïc Rivière; Ariel M Silber; Michael P Barrett; Alena Zíková; Michael Boshart; Jean-Charles Portais; Frédéric Bringaud
Journal:  PLoS Pathog       Date:  2021-03-01       Impact factor: 6.823

2.  Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion.

Authors:  Katsuhiko Warita; Tomoko Warita; Colin H Beckwitt; Mark E Schurdak; Alexei Vazquez; Alan Wells; Zoltán N Oltvai
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

Review 3.  Cofactors As Metabolic Sensors Driving Cell Adaptation in Physiology and Disease.

Authors:  Nabil Rabhi; Sarah Anissa Hannou; Philippe Froguel; Jean-Sébastien Annicotte
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-03       Impact factor: 5.555

4.  The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis.

Authors:  Long He; Shuting Wen; Zhuotai Zhong; Senhui Weng; Qilong Jiang; Hong Mi; Fengbin Liu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

5.  Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.

Authors:  Paula Korkuć; Dirk Walther
Journal:  Front Mol Biosci       Date:  2015-09-15

6.  Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.

Authors:  Andrea Cacace; Martina Sboarina; Thibaut Vazeille; Pierre Sonveaux
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 7.  Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.

Authors:  Marta F Bustamante; Ricard Garcia-Carbonell; Katrijn D Whisenant; Monica Guma
Journal:  Arthritis Res Ther       Date:  2017-05-31       Impact factor: 5.156

8.  4-octyl Itaconate inhibits lipopolysaccharide (LPS)-induced osteoarthritis via activating Nrf2 signalling pathway.

Authors:  Qingchen Zhang; Xiaohui Bai; Rongrong Wang; Hao Zhao; Lili Wang; Jingwen Liu; Ming Li; Zheng Chen; Zejun Wang; Lianxin Li; Dawei Wang
Journal:  J Cell Mol Med       Date:  2022-01-23       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.